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Anti-skin cancer potential of the macroalgae of Halimeda spp was tested against a skin cancer protein of  
4,5-Diarylisoxazole Hsp90 Chaperone by in silico docking method About 32 secondary metabolites of Halimeda spp. 
reported from previous studies were checked against the skin cancer protein of Hsp90 using the tool of Arguslab 4.0.1.  
To find out the relevance among skin cancer and other cancers, a phylogenetic tree was constructed for the skin cancer 
proteins and other cancer proteins. The association among the retention time, the molecular weight of the tested compounds, 
and docking run were tested using Pearson correlation analysis by Minitab tool. The result exhibited that most of the  
tested active principles are possessing considerable binding energy. Among them, the highest was recorded for  
1,2-Benzenedicarboxylic acid, butyl octyl ester of 14 kcal followed by Phthalic acid, butyl hexyl ester of 13 kcal.  
From the remaining four compounds showed 12 kcal, 14 compounds expressed 11 kcal and the other compounds 
possessed 10, 9, 8, and 4 kcal of binding energy. The phylogenetic tree revealed that the relationship of skin  
cancer having 100% similarity with other cancer protein of wild and home animals, 96% similarity with oral, lung  
and cervical cancers and 90% similarity with breast cancer protein in human. The correlation analysis showed that  
the positive association among the retention time, molecular weight of the compounds, and docking run. This study 
concludes that the Halimeda spp is the right candidate for culminating skin cancer and recommends further studies to 
establish the potential. 
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Cancer is one of the leading heat impacting and death-causing diseases worldwide. Cells of cancer divide  and grow uncontrollably and reach nearby parts of the body. Around 21.4 million cancer death will appear by 20301-3. Skin cancer is a growing unpleasant human disease compared to other cancer4. Marine is a source for novel pharmaceutical compounds1,5-7. The present study was carried out to identify the effect of secondary metabolites of the macroalgae of Halimeda spp against a skin cancer Hsp90 using Arguslab 4.0.1 and Pymol software. The evolutionary relationship of Hsp90 with lung cancer, breast cancer, oral cancer, and cervical cancer also established. The evolutionary relations of skin cancer in Humans with other wild and home animals of Giant panda, Cattle, Chinese hamster, Cat, Gray mouse lemur, house mouse, killer whale, Golden snub-nosed monkey, wild boar, Gelada was compared using MEGA-X. The correlation between docking binding energy, molecular weight, and retention time were carried in Minitab software. 
Materials and Methods  
Protein preparation  The sequence for the 4, 5-Diarylisoxazole Hsp90 
Chaperone skin cancer protein of Homo sapiens was 
taken from protein data bank (PDB) with id 2CVJ. 
The skin cancer protein sequences consist of a total 
count of 239 amino acids and having the resolution of 
2.0A (Table 2).  
 Compound Preparation  About 32 secondary metabolites were reported 
from the methanol and hexane extract of Halimeda 
spp8. The structure of these compounds obtained from 
Pubchem database as an SDF format and through 
simplified molecular input line entry specification 
(SMILES) notation the chemical structure of mol 
generated (Tables 1 & 3).  
 Docking and 3D structure exploration Arguslab 4.0.1a free docking tool was employed to check the antifouling potential of the chemicals. The 








Phylogenetic analysis  MEGA – X is one of the freely available common 
tolls was to develop an evolutionary tree. The 
percentage and similarity among the amino acid 
sequence of the Hsp90 gene in Giant panda, Cattle, 
Chinese hamster, Cat, Gray mouse lemur, house 
mouse, killer whale, and Golden snub-nosed monkey, 
wild boar and Gelada species was determined. 
Similarly, Homo sapiens skin cancer sequence 
analyzed with other cancer proteins of oral, cervical, 
breast, and lung cancer sequences. Sequences of 
above organism’s amino acid retrieved from NCBI 
and cluster and maximum likelihood tree build using 
MEGA-X software (Figs. 1 & 2).  
 
 
Table 1 — GC-MS of Methanol and Hexane extract (Gadhi et al., 2018) 
Sl. No Retantion time Compound name Solvent Formula Molecular weight g/mol 
1 557 Formamide, NN-dimethyl- Hexane C3H7NO 73.0938 
2 816 Octane Hexane C8H18 114.2285 
3 937 2-Methylaminomethyl-1,3-dioxolane Hexane C5H11NO2 117.148 
4 1440 Dimethyl phthalate Hexane/Methanol C10H10O4 194.1840 
5 1474 Mexiletine Hexane C11H17NO 179.2588 
6 1627 N-Isopropyl-3-phenylpropanamide Hexane C12H17NO 191.274 
7 1639 Diethyl phthalate Hexane/Methanol C12H14O4 222.2372 
8 1694 Ethyl N-isopropyl-3-phenylpropanimidate Hexane C14H21NO 219.328 
9 2007 Phenethylamine, N-methyl-beta.,3,4-
tris(trimethylsiloxy)- 
Hexane   
10 2136 Phthalic acid, hexyl propyl ester Hexane C17H24O4 292.375 
11 2434 1,2-Benzenedicarboxylic acid, butyl octyl 
ester 
Hexane C20H30O4 334.4498 
12 888 1-Cyclohexene, 1-ethynyl- Methanol C8H10 106.168 
13 1216 Decyltrifluoroacetate Methanol C12H21F3O2 254.2891 
14 1450 3-Trifluoroacetoxytridecane Methanol C15H27F3O2 296.374 
15 1450 4-Trifluoroacetoxytridecane Methanol   
16 1457 1-Dodecanol Methanol C12H26O 186.3342 
17 1508 Benzoic acid, 2-(1-oxopropyl)-,methyl 
ester 
Methanol C11H12O3 192.214 
18 1555 Phenol, 2,6-bis(1,1-dimethylethyl)- Methanol C14H22O 206.3239 
19 1556 n-Tridecan-1-ol Methanol C13H28O 200.3608 
20 1613 Tetradecyltrifluoroacetate Methanol C16H29F3O2 310.3955 
21 1669 4-Heptafluorobutyryloxyhexadecane Methanol C20H33F7O2 438.471 
22 1729 Phthalic acid, allyl ethyl ester Methanol C13H14O4 234.2479 
23 1773 Pentafluoropropionic acid, hexadecyl ester Methanol C19H33F5O2 388.4561 
24 1818 5-Octadecene, (E)- Methanol C18H36 252.4784 
25 1854 1-Hexadecanol Methanol C16H34O 242.4406 
26 1855 Carbonic acid, methyl tetradecyl ester Methanol C16H32O3 272.4235 
27 1954 n-Heptadecanol-1 Methanol C17H36O 256.4671 
28 1973 1,2-Benzenedicarboxylic acid, butyl 2-
methylpropyl ester 
Methanol C16H22O4 278.3435 
29 2037 Dibutyl phthalate Methanol C16H22O4 278.3435 
30 2235 Phthalic acid, butyl hexyl ester Methanol C18H26O4 306.3966 
31 2259 Dichloroacetic acid, 4-hexadecyl ester Methanol C18H34Cl2O2 353.368 
32 2774 6,9,12-Octadecatrienoic acid, 
phenylmethyl ester, (Z,Z,.Z)- 
Methanol C25H36O2 368.561 





Table 2 — Skin cancer details and structure (Protein Data Bank., 2019) 
Sl. No Protein Name PDB-ID Method Organims Structure 
1 4,5 Diaryl 
Isoxazole Hsp90 
Chaperone 
2VCJ X-Ray diffraction Homo sapiens 
 
 
Table 3 — Halimeda spp compound name structure and Binding energy vs Skin cancer protein (Contd.) 
Sl. No Compound name  Chemical structure Binding energy 
kcal/mol 2VCJ Skin 
cancer 


























Table 3 — Halimeda spp compound name structure and Binding energy vs Skin cancer protein (Contd.) 
Sl. No Compound name  Chemical structure Binding energy 








10 5-Octadecene, (E)-  11.6925 




12 Benzoic acid, 2-(1-oxopropyl)-,methyl ester 
 
10.767 














Table 3 — Halimeda spp compound name structure and Binding energy vs Skin cancer protein (Contd.) 
Sl. No Compound name  Chemical structure Binding energy 
kcal/mol 2VCJ Skin 
cancer 
16 Dichloroacetic acid, 4-hexadecyl ester 
 
12.2967 
17 Diethyl phthalate 
 
10.2886 
18 Dimethyl phthalate 
 
9.20156 
19 Ethyl N-isopropyl-3-phenylpropanimidate 
 
8.16888 















Table 3 — Halimeda spp compound name structure and Binding energy vs Skin cancer protein 
Sl. No Compound name  Chemical structure Binding energy 








26 Pentafluoropropionic acid, hexadecyl ester 
 
11.2092 
27 Phenol, 2,6-bis(1,1-dimethylethyl)- 
 
11.8958 
28 Phthalic acid, allyl ethyl ester 
 
10.7089 
29 Phthalic acid, butyl hexyl ester 
 
13.2064 







Statistical analysis  The relationship between molecular weight, 
retention time, binding energy, and elapse time was 
checked by using Minitab 14.1.  
 Results  
Molecular docking  Target drug discovery involves the identification of 
potential lead molecules against the skin cancer-causing 
receptor molecules. There are 31 bioactive secondary 
metabolites that were screened against skin cancer  
(4,5-Diarylisoxazole Hsp90 Chaperone) protein  
using Arguslab 4.0.1 (Table 3). In 31 compounds,  
1,2-Benzenedicarboxylic acid, butyl octyl ester of 
hexane extract showed 14.27 followed by Phthalic 
acid, butyl hexyl ester (13.2064 binding energy),  
4-Heptafluorobutyryloxyhexadecane, Phthalic acid, hexyl 




propyl ester, Dichloroacetic acid, 4-hexadecyl ester and 
1-Cyclohexene, 1-ethynyl- (around 12 binding energy). 
Compounds of Dibutyl phthalate,  
N-Isopropyl-3-phenylpropanamide, n-Tridecan-1-ol, 
Phenol, 2,6-bis(1,1-dimethylethyl)-, 1-Hexadecanol, 1,2-
Benzenedicarboxylic acid, butyl 2-methylpropyl  
ester, n-Heptadecanol-1, 5-Octadecene, (E)-, 3-
Trifluoroacetoxytridecane, Octane, 4-Trifluoroace 
toxytridecane, Tetradecyltrifluoroacetate, Pentafluoro 
propionic acid, hexadecyl ester and 1-Dodecanol 
showed around (11 binding energy), Carbonic acid, 
methyl tetradecyl ester, Benzoic acid, 2-(1-oxopropyl)-, 
methyl ester, Phthalic acid, allyl ethyl ester, 
Decyltrifluoroacetate, and Decyltrifluoroacetate having 
(10 binding energy), 9 binding hold by Dimethyl 
phthalate, Mexiletine, Ethyl N-isopropyl-3-
phenylpropanimidate having 8 binding energy and 
compounds of 2-Methylaminomethyl-1,3-dioxolane and 
Formamide, NN-dimethyl-binding energy around 4.  
 Phylogenetic tree  Percentage identification among protein sequence of Homo sapiens Hsp90 protein wild and home animals like Giant panda, Cattle, Chinese hamster, Cat, Gray mouse lemur, house mouse, killer whale, and  
 
  Fig. 1 — Evolutionary relationship of skin cancer protein with other organism (MEGA-X) 





  Fig. 2 — Skin cancer protein vs other cancer protein relationship 
 
  Fig. 3 — Three dimensional view of (A) 1,2-Benzenedicarboxylic acid, butyl 2-methylpropyl ester vs 2VCJ (PyMOL); (B) 1,2-
Benzenedicarboxylic acid, butyl octyl ester vs 2VCJ (PyMOL); (C) 1-Dodecanol vs Hsp90 (PyMOL); (D) 4-Heptafluorobutyryloxyhexadecane 
vs 2 VCJ (PyMOL); and (E) Dichloroacetic acid, 4-hexadecyl ester vs Hsp90 (PyMOL)yo 




 Golden snub-nosed monkey, wild boar and Gelada species and other cancer protein of oral, cervical, 
breast and lung cancer. Skin cancer protein 100 percentages similar to other Giant pandas, Cattle, Chinese hamster, Cat, Gray mouse lemur, house mouse, killer whale, and Golden snub-nosed monkey, wild boar and Gelada species protein in cluster analysis. Cluster percentage similarity study of skin 
cancer protein 90% match with breast cancer protein, 96 % similarity with oral, cervical, and lung cancer (Figs. 1 & 2).  
 Statistics  The correlation analyses were carried out using 
Minitab 14.1. software. It was scrutinized that there 
were a strong positive relationship between molecular 
weight with retention time (0.72), elapse time with 
retention time (0.20) and molecular weight with 
elapse time (0.14). The study reveals that there is a 
negative relationship between binding energy with 
retention time (0.13) molecular weight (0.20) and 
elapsed time (0.21). According to the correlation 
study strong relation of molecular weight with 
retention time and elapse time and retention time with 
molecular weight and elapse time.  
 Discussion  The present study shows that around 27 compounds 
are having high lower docking energy and 3 having 
low lower docking values in 31 compounds. Four 
compounds having potential against Hsp90 protein was 
studied by Sakkiah et al. (2011)9. Yang et al. (2011) 
studied pyrazole and isoxazole based Hsp90 inhibitors 
and they observed that 5-amides substituent is 
enhanced the activity against skin cancer protein10. 
Compounds of cocaine, lapatinib, cabazitaxel, 
apraclonidine, and Dyclonine was studied against  
four cancer protein in it Hsp90 is one of them and 
molecular study reveals that cabazitaxel having 
potential against skin cancer and brain cancer2. Fungal 
metabolites of four compounds were studied against 
skin cancer protein by Kandasamy et al. (2012) and 
9,12-Octadecadienoic acid (11) showed high bind 
energy and other 3 compounds are showing (10, 9 
and 8)11. Sangeetha et al. (2014) employed the 
cyanobacterium against cancer protein and found 
cryptophcin can be an alternative for treating cancer 
protein12. Verma et al. (2017) also observed that the 
cyanobacterium is a potential candidate against cancer 
through the in silico, in vitro and in vivo methods  
and brought into considering for treating cancer3.  
N-benzoyl-N-phenyl thiourea synthesis was employed 
against Hsp90 protein through in silico and reveals that 
good inhibitor for skin cancer13. 
 Conclusion This is the first molecular docking study using the 
macroalgae of Halimeda spp against skin cancer. The 
present study showed that based on molecular 
docking binding energy Halimeda species secondary 
metabolites could be a potent inhibitor against skin 
cancer-causing protein Hsp90. This current research 
also suggests that further exploration of the utility and 
molecular mechanisms of the compound will facilitate 
a better understanding of being in command of skin 
cancer and to develop drugs to cure cancer.  
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